Acadian Asset Management’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$109K Sell
22,496
-1,700
-7% -$10.6K ﹤0.01% 1740
2026
Q1
$189K Hold
24,196
﹤0.01% 1606
2025
Q4
$284K Sell
24,196
-1,372
-5% -$11.8K ﹤0.01% 1448
2025
Q3
$204K Sell
25,568
-21,120
-45% -$147K ﹤0.01% 1397
2025
Q2
$372K Hold
46,688
﹤0.01% 1197
2025
Q1
$328K Sell
46,688
-457
-1% -$4.94K ﹤0.01% 1163
2024
Q4
$533K Sell
47,145
-919
-2% -$12K ﹤0.01% 1061
2024
Q3
$671K Hold
48,064
﹤0.01% 1015
2024
Q2
$762K Hold
48,064
﹤0.01% 1079
2024
Q1
$1.3M Buy
48,064
+17,830
+59% +$429K ﹤0.01% 776
2023
Q4
$610K Hold
30,234
﹤0.01% 982
2023
Q3
$396K Buy
30,234
+1,294
+4% +$21.3K ﹤0.01% 1063
2023
Q2
$543K Hold
28,940
﹤0.01% 1039
2023
Q1
$553K Hold
28,940
﹤0.01% 1026
2022
Q4
$798K Buy
28,940
+4,062
+16% +$102K ﹤0.01% 901
2022
Q3
$620K Buy
24,878
+3,900
+19% +$154K ﹤0.01% 938
2022
Q2
$990K Buy
20,978
+12,965
+162% +$606K 0.01% 820
2022
Q1
$496K Buy
+8,013
New +$660K ﹤0.01% 1000

Other funds holding PASG

Acadian Asset Management's PASG Position: Q2 2026 in Review

Acadian Asset Management reduced its Passage Bio (PASG) stake by 7% in Q2 2026, selling an estimated $10.6K and leaving 22,496 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1740.

Acadian Asset Management first reported a position in PASG in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.3M in Q1 2024. 28 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • Acadian Asset Management held 22,496 shares of Passage Bio worth $109K as of Q2 2026.
  • Acadian Asset Management sold 1,700 Passage Bio shares in Q2 2026, an estimated $10.6K.
  • Passage Bio made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1740 holding.
  • Acadian Asset Management first reported a position in Passage Bio in Q1 2022 and has held it in 18 quarters since.
  • Acadian Asset Management's Passage Bio position peaked at $1.3M in Q1 2024.
  • 28 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.